Greg Yap
Partner·Menlo Ventures
Bio
Professional summary
Greg Yap is a Partner at Menlo Ventures investing in teams solving major problems in life science and healthcare. His stated areas of interest include novel therapeutic platforms, digital health, and transformative technologies, with Menlo also tagging his profile for Bio + Healthcare and AI. Before Menlo, he was an entrepreneur-in-residence at Illumina Ventures focused on genomics investments and spent two decades in senior executive and entrepreneurial roles in life science and digital health. He co-founded and led BlueLight Therapeutics and PyrAmes, and previously held leadership roles at Roche Diagnostics/Ventana, GE, Cellpoint Diagnostics, Affymetrix, and McKinsey.
Investment focus
Stage, sector, and overall fit
Stage
Sector
Thesis
Notable companies
Selected portfolio companies the partner has backed
How to approach
Framing and angles for outreach
Pitch framing
Lead with a rigorous healthcare or life-science thesis, the scientific or clinical wedge, and why the team can translate technology into a scalable company. He appears especially relevant for AI-enabled therapeutics, genomics, digital health, and platforms that connect deep biology with large healthcare problems.
Partneralization hooks
- 1Reference his operating history in life science and diagnostics when pitching clinical translation or commercialization.
- 2Use Genesis, Delfi, Chai Discovery, or Recursion as hooks for AI-enabled biology or diagnostics.
- 3Use Cartwheel, Ophelia, H1, or Particle Health as hooks for digital health and healthcare data platforms.
- 4Mention his genomics focus from Illumina Ventures if the company is genomics-related.
Recent signals
What the partner has said or done recently
Menlo profile lists Chai Discovery as a 2025 Series A partnership focused on AI models for biochemical interactions.
Menlo profile lists Aurora Therapeutics as a 2025 company incubated by Menlo Ventures, with Greg Yap shown as a partner.
Menlo profile highlights his Aspen Health Innovators Fellowship and Aspen Global Leadership Network membership.
Other partners at Menlo Ventures
12 more profiles
Amy Wu Martin
Partner
Menlo Ventures
Amy Wu Martin is a Partner at Menlo Ventures focused on AI and consumer companies, with a background in consumer technology, gaming, blockchain, and digital media. She joined Menlo to grow its consumer technology and gaming practice.
C.C. Gong
Principal
Menlo Ventures
Menlo principal investing in consumer tech, SaaS, and AI applications.
Croom Beatty
Partner
Menlo Ventures
Croom Beatty is a Partner at Menlo Ventures focused on application-layer AI, fintech, healthcare IT, and vertical software. Since joining Menlo in 2017, he has led investments in companies including Arch, Finch, Manifest, NationGraph, Numeric, Prodigal, Rivet, Slash, Abacus, Accordance, Relcu, and Squad Health.
Deborah Carrillo
General Counsel, Partner
Menlo Ventures
General Counsel and Partner overseeing legal, fund, deal, and compliance work at Menlo.
Deedy Das
Partner
Menlo Ventures
Early-stage AI, infrastructure, and enterprise software investor; ex-Glean, Google, and Facebook.
Derek Xiao
Principal
Menlo Ventures
Menlo principal backing AI, cloud infrastructure, and digital health startups.
Doug Carlisle
Partner Emeritus
Menlo Ventures
Longtime Menlo IT investor behind Hotmail, IronPort, Ansible, nLight, and Synthego.
Houman Haghighi
Partner, Business & Corporate Development
Menlo Ventures
Business development partner helping Menlo portfolio companies scale through partnerships.
Ishika C.
Investor
Menlo Ventures
Menlo investor focused on AI/ML, SaaS, and cloud infrastructure.
Joff Redfern
Partner
Menlo Ventures
Joff Redfern is a partner at Menlo Ventures focused on software development workflows, AI-driven future-of-work products, and network-effect businesses including marketplaces.
Johnny Hu
Principal
Menlo Ventures
Menlo principal investing in biotech, life sciences, and novel therapeutics.
JORDAN ORMONT
Partner, Talent
Menlo Ventures
Talent partner helping founders build management teams, boards, and recruiting pipelines.